Explore how high-throughput, multi-attribute protein characterization can support formulation development by evaluating ...
Discover how secondary antibodies enhance protein detection, improve assay sensitivity, and support reliable results across ...
BACKGROUND: Metabolic adaptation and maladaptation are hallmarks of the failing heart and may be a target for therapeutic ...
Background Pancreatic ductal adenocarcinoma (PDAC) is largely refractory to immune checkpoint blockade, owing to its ...
Chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) has rapidly emerged as a pivotal tool in neuroimaging, enabling the ...
A commercial assay that measures eMTBR-tau may be an alternative to tau PET imaging in diagnosing Alzheimer’s disease, according to data presented at the Alzheimer’s Association International ...
Genopore, the next-generation proteomics company developing the first semiconductor based optical nanopore technology platform with AI/ML analysis for direct single protein molecule identification and ...
PMN310 demonstrated dose-dependent reduction of amyloid-beta oligomers in human cerebrospinal fluid following a single dose in healthy volunteers ...
This infographic explores a scalable systems-level proteomics approach that reveals novel biomarker candidates and deepens understanding of neurological disease mechanisms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results